Algae-Derived Bioactive Molecules for the Potential Treatment of SARS-CoV-2
Open accessThe DOI matches its Crossref record; 116 of the 116 references it cites were found in a registry or an index.
Abstract
The recently emerged COVID-19 disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has adversely affected the whole world. As a significant public health threat, it has spread worldwide. Scientists and global health experts are collaborating to find and execute speedy diagnostics, robust and highly effective vaccines, and therapeutic techniques to tackle COVID-19. The ocean is an immense source of biologically active molecules and/or compounds with antiviral-associated biopharmaceutical and immunostimulatory attributes. Some specific algae-derived molecules can be used to produce antibodies and vaccines to treat the COVID-19 disease. Algae have successfully synthesized several metabolites as natural defense compounds that enable them to survive under extreme environments. Several algae-derived bioactive molecules and/or compounds can be used against many diseases, including microbial and viral infections. Moreover, some algae species can also improve immunity and suppress human viral activity. Therefore, they may be recommended for use as a preventive remedy against COVID-19. Considering the above critiques and unique attributes, herein, we aimed to systematically assess algae-derived, biologically active molecules that could be used against this disease by looking at their natural sources, mechanisms of action, and prior pharmacological uses. This review also serves as a starting point for this research area to accelerate the establishment of anti-SARS-CoV-2 bioproducts.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![Figure 2 The putative association between ACE2 shedding after SARS-CoV-2 infection. Reprinted from Viana et al. [56] with permission from Elsevier. Copyright 2021, Elsevier. License Number: 4993920853888.](https://figures.cochat.ai/paper-figures/5a210fbc15f54785af3e5e68483d9cb7/algae-derived-bioactive-molecules-for-the-potential-treatment-of-sars-cov-2-figure-2.jpg)

![Figure 4 An array of algae-based antioxidants. The inner circle shows the diversity of biologically active antioxidants produced in a marine environment. The outer circle represents their novel therapeutic and biomedical potentialities. Reprinted from Bilal and Iqbal [101] with permission from Elsevier. Copyright 2021 Elsevier B.V. License Number: 4982940408845.](https://figures.cochat.ai/paper-figures/f5c156ddf96d45948304802cdef5e2ec/algae-derived-bioactive-molecules-for-the-potential-treatment-of-sars-cov-2-figure-4.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Other active compounds in microalgae such as astaxanthin from green microalga Haematococcus pluvialis and sulfated polysaccharides from red microalga Porphyridium sp. additionally possess antiviral properties (Alam et al., 2021).”
From Cyanobacteria and microalgae in supporting human habitation on Mars (2022) · cites this paper as Alam et al., 2021
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286 · cited 1×
“TMPRSS2 (a human serine protease) is responsible for priming the S-glycoprotein of SARS-CoV-2, and the human angiotensin-converting enzyme 2 (hACE2) is engaged as a receptor for the entry of SARS-CoV-2 [83].”
BackgroundCryo-EM structure of the 2019-nCoV spike in the prefusion conformation
Wrapp, D., Wang, N., Corbett, K. S., Goldsmith, J. A., Hsieh, C.-L., Abiona, O., Graham, B. S., & McLellan, J. S. (2020) · Science · doi:10.1126/science.abb2507 · Cited by 8,897 · cited 1×
“[82] reported that the S-glycoprotein of SARS-CoV-2 contains 66 glycosylation sites.”
BackgroundRole of gut microbiota in type 2 diabetes pathophysiology
Gurung, M., Li, Z., You, H., Rodrigues, R., Jump, D. B., Morgun, A., & Shulzhenko, N. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2019.11.051 · Cited by 1,708 · cited 1×
“Gut microbiome dysbiosis, which is known for the resultant alterations of gut microbiota, has also been shown as related to several diseases and disorders, such as depression [52], obesity [53], IBS [54], and type-2 diabetes [55].”
BackgroundCoronaviruses — drug discovery and therapeutic options
Zumla, A., Chan, J. F. W., Azhar, E. I., Hui, D. S. C., & Yuen, K.-Y. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2015.37 · Cited by 1,707 · cited 2×
“The red algae-derived high-mannose-binding lectin of 121 amino acids (namely, Griffithsin (GRFT)) is reported to inhibit SARS-CoV entry by specifically binding to the spike glycoprotein [37,39].”
BackgroundCheung, K. S., Hung, I. F. N., Chan, P. P. Y., Lung, K. C., Tso, E., Liu, R., Ng, Y. Y., Chu, M. Y., Chung, T. W. H., Tam, A. R., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.03.065 · Cited by 1,631 · cited 1×
“Approximately 20% of patients with SARS-CoV-2 exhibit GI problems, as reported by a Hong Kong cohort study [46].”
BackgroundSite-specific glycan analysis of the SARS-CoV-2 spike
Watanabe, Y., Allen, J. D., Wrapp, D., McLellan, J. S., & Crispin, M. (2020) · Science · doi:10.1126/science.abb9983 · Cited by 1,548 · cited 1×
“Another study [81] has been performed to identify the location of 22 glycosylation sites, where glycans are attached to the SARS-CoV-2 spike and form sugar at each site.”
BackgroundAlterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization
Zuo, T., Zhang, F., Lui, G. C. Y., Yeoh, Y. K., Li, A. Y. L., Zhan, H., Wan, Y., Chung, A. C. K., Cheung, C. P., Chen, N., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.05.048 · Cited by 1,537 · cited 2×
“This study also found that patients with COVID-19 have higher levels of the harmful microbes Actinomyces viscosus, Bacteroides nordii, and Clostridium hathewayi and lower levels of the friendly microbes Faecalibacterium prausnitzii, Lachnospiraceae bacterium, Eubacterium rectale, Ruminococcus obeum, and Dorea formicig…”
ResultGastrointestinal symptoms of 95 cases with SARS-CoV-2 infection
Lin, L., Jiang, X., Zhang, Z., Huang, S., Zhang, Z., Fang, Z., Gu, Z., Gao, L., Shi, H., Mai, L., et al. (2020) · Gut · doi:10.1136/gutjnl-2020-321013 · Cited by 924 · cited 1×
“Another study analyzed 95 patients with this virus [47].”
BackgroundGut microbiota and Covid-19- possible link and implications
Dhar, D., & Mohanty, A. (2020) · Virus Research · doi:10.1016/j.virusres.2020.198018 · Cited by 608 · cited 1×
“Nevertheless, a healthy gut microbiome is crucial for its supportive role in antiviral immunity [50], and improving gut flora by maintaining a nutritional diet is essential for strengthening the gut microbiota to attenuate the effect of novel SARS-CoV-2 [51].”
BackgroundOxidative Stress as Key Player in Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) Infection
Delgado-Roche, L., & Mesta, F. (2020) · Archives of Medical Research · doi:10.1016/j.arcmed.2020.04.019 · Cited by 604
Research works printed but not linked: 3
- 2014, Antiviral activity of an aqueous extract from the red alga Laurencia obtusa against influenza A and B viruses, Rev. Cuba. Med. Trop., 66, 273
- Sundararaj, 2020, Algae: A potential source to prevent and cure the novel coronavirus–A review, Int. J. Emerg. Technol., 11, 479
- Nikunj, 2020, Lensi P, Richa P, haresh P, Red algae derived phycocompounds as an inhibitors of SARS-CoV-2, J. Interdiscip. Cycle Res., 12, 662
Cited by
Carlini, V., Noonan, D. M., Abdalalem, E., Goletti, D., Sansone, C., Calabrone, L., & Albini, A. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1161067 · Cited by 543
Seaweed Components as Potential Modulators of the Gut Microbiota
Shannon, E., Conlon, M., & Hayes, M. (2021) · Marine Drugs · doi:10.3390/md19070358 · Cited by 157
“The potential bioactivity of seaweed components has been demonstrated previously in in vitro studies [35,36], however the impact of gastrointestinal enzymatic digestion and colonic bacterial fermentation in vivo must also be considered, since it may have an effect on the bioavailability of prebiotic and other actives…”
BackgroundBioactive compounds by microalgae and potentials for the management of some human disease conditions
Eze, C. N., Onyejiaka, C. K., Ihim, S. A., Ayoka, T. O., Aduba, C. C., Ndukwe, J. K., Nwaiwu, O., & Onyeaka, H. (2023) · AIMS Microbiology · doi:10.3934/microbiol.2023004 · Cited by 95
Cyanobacteria and microalgae in supporting human habitation on Mars
Mapstone, L. J., Leite, M. N., Purton, S., Crawford, I. A., & Dartnell, L. (2022) · Biotechnology Advances · doi:10.1016/j.biotechadv.2022.107946 · Cited by 92
“Other active compounds in microalgae such as astaxanthin from green microalga Haematococcus pluvialis and sulfated polysaccharides from red microalga Porphyridium sp. additionally possess antiviral properties (Alam et al., 2021).”
Evaluation of Microalgae Antiviral Activity and Their Bioactive Compounds
Carbone, D. A., Pellone, P., Lubritto, C., & Ciniglia, C. (2021) · Antibiotics · doi:10.3390/antibiotics10060746 · Cited by 95
Therapeutic activity of fucoidan and carrageenan as marine algal polysaccharides against viruses
Oliyaei, N., Moosavi‐Nasab, M., & Mazloomi, S. M. (2022) · 3 Biotech · doi:10.1007/s13205-022-03210-6 · Cited by 83
Moura, M. A. F. E., Martins, B. D. A., Oliveira, G. P. D., & Takahashi, J. A. (2023) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2022.2085657 · Cited by 78
“Alam et al. (2021) highlighted the potential of A. platensis to inhibit the entry of SARS CoV-2 pseudovirus in Vero E6 cell culture and related the inhibition to algae metabolites, such as sulfated polysaccharides, that can bind to the glycoprotein in the viral envelope, preventing the virus from…”
BackgroundMoradi, M., Golmohammadi, R., Najafi, A., Moghaddam, M. M., Fasihi‐Ramandi, M., & Mirnejad, R. (2022) · Informatics in Medicine Unlocked · doi:10.1016/j.imu.2022.100862 · Cited by 87
“[51] Red Algae n-Decanoic acid and 9-dodecenoic”
Saied, E. M., El‐Maradny, Y. A., Osman, A. A., Darwish, A. M. G., Nahas, H. H. A., Niedbała, G., Piekutowska, M., Abdel-Rahman, M. A., Balbool, B. A., & Abdel-Azeem, A. M. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13111759 · Cited by 65
Akbari, A., Bigham, A., Rahimkhoei, V., Sharifi, R., & Jabbari, E. (2022) · Polymers · doi:10.3390/polym14091634 · Cited by 58
Pradhan, B., Nayak, R., Patra, S., Bhuyan, P. P., Dash, S. R., Ki, J., Adhikary, S. P., Ragusa, A., & Jena, M. (2022) · Antioxidants · doi:10.3390/antiox11020354 · Cited by 61
Microalgal drugs: A promising therapeutic reserve for the future
Ahirwar, A., Kesharwani, K., Deka, R., Muthukumar, S., Khan, M. J., Rai, A., Vinayak, V., Varjani, S., Joshi, K. B., & Morjaria, S. (2022) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2022.03.012 · Cited by 55
Ashokkumar, V., Shanmugam, J., Kumar, G., Sharmili, S. A., Gopal, M., Dharmaraj, S., Chen, W., Kothari, R., Manasa, I., Park, J. H., et al. (2022) · Bioresource Technology · doi:10.1016/j.biortech.2022.127235 · Cited by 58
Biopharmaceutical applications of microbial polysaccharides as materials: A Review
Song, Y., Li, S., Hao, G., Yip, R. C. S., & Chen, H. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.124259 · Cited by 56
Zahmatkesh, S., Amesho, K. T. T., & Sillanpää, M. E. T. (2022) · Journal of Hazardous Materials Advances · doi:10.1016/j.hazadv.2022.100121 · Cited by 54
A Review of Marine Algae as a Sustainable Source of Antiviral and Anticancer Compounds
Kumar, A., Soratur, A., Kumar, S., & Maran, B. A. V. (2025) · Macromol—A Journal of Macromolecular Research · doi:10.3390/macromol5010011 · Cited by 53
Ashour, M., & Omran, A. M. M. (2022) · Fermentation · doi:10.3390/fermentation8090466 · Cited by 44
Microalgae: A Promising Source of Bioactive Polysaccharides for Biotechnological Applications
Magnabosco, C., Santaniello, G., & Romano, G. (2025) · Molecules · doi:10.3390/molecules30092055 · Cited by 43
“Currently, several emerging viruses are rapidly isolated, many of which are drug-or vaccine-resistant; therefore, there is a great need to find new antiviral agents [64,68,69].”
Bioprospecting microalgae and cyanobacteria for biopharmaceutical applications
Saeed, M. U., Hussain, N., Shahbaz, A., Hameed, T., Iqbal, H. M. N., & Bilal, M. (2021) · Journal of Basic Microbiology · doi:10.1002/jobm.202100445 · Cited by 40
“Antiviral compounds identified from cyanobacteria are rare in comparison to antifungal and antibacterial compounds, even though 2%–10% of extracts from several cyanobacterial species have been found to exhibit antiviral properties [137].”
BackgroundSelf-citationOliyaei, N., Tanideh, N., Moosavi‐Nasab, M., Dehghanian, A., & Iraji, A. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.123867 · Cited by 41
Ahmed, M. N., Jahan, R., Nissapatorn, V., Wilairatana, P., & Rahmatullah, M. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112507 · Cited by 37
“[141], and can be potent inhibitors of coronaviruses as well.”
Self-citationFlavonoids derived from medicinal plants as a COVID ‐19 treatment
Sopjani, M., Falco, F., Impellitteri, F., Guarrasi, V., Thi, X. N., Dërmaku‐Sopjani, M., & Faggio, C. (2024) · Phytotherapy Research · doi:10.1002/ptr.8123 · Cited by 39
Antiviral Activity of Two Marine Carotenoids against SARS-CoV-2 Virus Entry In Silico and In Vitro
Yim, S.-K., Kim, I.-H., Warren, B., Kim, J., Jung, K.-J., & Ku, B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126481 · Cited by 37
“Although carotenoids are known to have beneficial effects on health and diverse applications [32], such as antibacterial, antiviral, antifungal, anticancer, antidiabetic, anti-inflammatory, antioxidant, anti-obesity, and neuroprotective applications, there are no studies related to how marine carotenoids can inhibit S…”
BackgroundTruths and myths about superfoods in the era of the COVID-19 pandemic
Hassoun, A., Harastani, R., Jagtap, S., Trollman, H., Garcia‐Garcia, G., Awad, N. M. H., Zannou, O., Galanakis, C. M., Gökşen, G., Nayik, G. A., et al. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2022.2106939 · Cited by 37
“However, reviews by Alam et al. (2021) and Vishwakarma et al. (2022) suggested that superfoods including algae-derived bioactive molecules and spirulina and chlorella can reduce acute respiratory infections due to their antiviral properties.”
BackgroundShahid, A., Fan, Z., Su, K., Zhao, A., Mehmood, M. A., Chang, J.-S., Solovchenko, A. E., Alam, M. A., & Xu, J. (2025) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2025.104886 · Cited by 28
Self-citationKalasariya, H. S., Patel, N. B., Gacem, A., Alsufyani, T. A., Reece, L. M., Yadav, V. K., Awwad, N. S., Ibrahium, H. A., Ahn, Y., Yadav, K. K., et al. (2022) · Marine Drugs · doi:10.3390/md20090586 · Cited by 29
“as well as some other marine algae such as Laurencia papillosa, Gracilaria corticata and Grateloupia filicina-derived compounds, on different target proteins of SARS-CoV-2 [37].”
BackgroundMaliki, I. M., Misson, M., Teoh, P. L., Rodrigues, K. F., & Yong, W. T. L. (2022) · Marine Drugs · doi:10.3390/md20020102 · Cited by 28
Ahmed, M. N., & Hughes, K. (2022) · Beni-Suef University Journal of Basic and Applied Sciences · doi:10.1186/s43088-022-00277-1 · Cited by 24
“Medicinal plants that have supportive roles in immune stimulation and maintenance of a balanced gut microbiome may be effective strategies for the management of COVID-19 [35] as a healthy gut microbiota is essential for a strong antiviral immunity [8].”
BackgroundSelf-citationGunaseelan, S., Arunkumar, M., Aravind, M. K., Gayathri, S., Rajkeerthana, S., Mohankumar, V., Ashokkumar, B., & Varalakshmi, P. (2022) · Molecular Diversity · doi:10.1007/s11030-022-10383-y · Cited by 21
“1 3 An increasing number of reports on phlorotannins as broad-spectrum antiviral agents against SARS-CoV-1 [9], PEDV [22], influenza virus [10], HIV-1 [12], HPV [11], VHSV ([14]), and MNV [12, 16] implies their importance as alternative natural therapeutic candidates.”
BackgroundLignocellulosic biomass-based glycoconjugates for diverse biotechnological applications
Reis, C. E. R., Milessi, T. S., Ramos, M. D. N., Singh, A. K., Mohanakrishna, G., Aminabhavi, T. M., Kumar, P. S., & Chandel, A. K. (2023) · Biotechnology Advances · doi:10.1016/j.biotechadv.2023.108209 · Cited by 24
Ziyaei, K., Ataie, Z., Mokhtari, M., Adrah, K., & Daneshmehr, M. A. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.03.063 · Cited by 26
“Among the compounds derived from algae, SPs such as agar, alginate, or carrageenan and PUFAs are highlighted because extracted SPs and PUFAs have been shown to possess a variety of biological properties such as immunomodulator [9,93,101], antioxidant [102,103], antiinflammatory, anticoagulant, antitumor, antiviral [9,…”
The Ocean’s Pharmacy: Health Discoveries in Marine Algae
Silva, M., Avni, D., Varela, J. C. S., & Barreira, L. A. (2024) · Molecules · doi:10.3390/molecules29081900 · Cited by 21
Kaur, S., Sharma, A., Bala, S., Satheesh, N. K., Nile, A. S., & Nile, S. H. (2025) · Bioresource Technology · doi:10.1016/j.biortech.2025.132424 · Cited by 20
Algal Metabolites Can Be an Immune Booster against COVID-19 Pandemic
Kumar, A., Singh, R. P., Kumar, I., Yadav, P., Singh, S. K., Kaushalendra, K., Singh, P. K., Gupta, R. K., Singh, S. M., Kesawat, M. S., et al. (2022) · Antioxidants · doi:10.3390/antiox11030452 · Cited by 21
Broad Spectrum Algae Compounds Against Viruses
Reis, J. G., Cadamuro, R. D., Cabral, A. C., Silva, I. T., Rodríguez-Làzaro, D., & Fongaro, G. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.809296 · Cited by 18
A review on the expanding biotechnological frontier of Pedobacter
Figueiredo, G., Osório, H., Mendes, M. V., & Mendo, S. (2025) · Biotechnology Advances · doi:10.1016/j.biotechadv.2025.108588 · Cited by 13
Semenova, M. G., Antipova, A. S., Martirosova, E. I., Chebotarev, S. A., Palmina, N. P., Bogdanova, N. G., Krikunova, N. I., Zelikina, D. V., Anokhina, M. S., & Kasparov, V. V. (2022) · Food & Function · doi:10.1039/d1fo03336k · Cited by 11
Anurans against SARS-CoV-2: A review of the potential antiviral action of anurans cutaneous peptides
de Amaral, M., & Ienes-Lima, J. (2022) · Virus Research · doi:10.1016/j.virusres.2022.198769 · Cited by 10
Zelikina, D. V., Chebotarev, S. A., Komarova, A., Balakina, E., Antipova, A. S., Martirosova, E. I., Anokhina, M. S., Palmina, N. P., Bogdanova, N. G., Lysakova, E. V., et al. (2022) · Colloids and Surfaces A Physicochemical and Engineering Aspects · doi:10.1016/j.colsurfa.2022.129630 · Cited by 10
Sruthy, E. S., & Baiju, E. K. C. (2024) · Botanica Serbica · doi:10.2298/botserb2402127s · Cited by 10
Tilapia lake virus: understanding incidence, enhancing resistance, and exploring seaweed therapies
Debbarma, S., Yadav, N. K., Devi, N. C., Bagthasingh, C., Yirang, Y., Meena, D. K., Singh, S. K., Mehta, N. K., & Mocherla, B. P. (2024) · Aquaculture International · doi:10.1007/s10499-024-01663-5 · Cited by 9
“These compounds and extracts from algae are also inexpensive (Alam et al. 2021).”
Snoussi, M., Noumi, E., Mosbah, A., Redissi, A., Saeed, M., Tasleem, M., Alreshidi, M. M., Adnan, M., ALrashidi, A. A., Siddiqui, A. J., et al. (2022) · Cellular and Molecular Biology · doi:10.14715/cmb/2021.67.4.17 · Cited by 8
“Introduction The recently declared pandemic coronavirus disease 19 (COVID-19) that causes severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a serious global threat to public health-endangering people‘s life and floundering in global crisis (1, 2).”
BackgroundSecret heroes of the sea: brown macroalgae and their bioactive powers—a narrative review
Başak, C. A. N., & Şanlıer, N. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1766041 · Cited by 8
Snoussi, M., Ahmad, I., Patel, H., Noumi, E., Zrieq, R. M., Saeed, M., Sulaiman, S., Khalifa, N. E., Chabchoub, F., Feo, V. D., et al. (2022) · Pharmacognosy Magazine · doi:10.4103/pm.pm_251_22 · Cited by 7
Afroze, C. A., Ahmed, M. N., Jahan, R., & Rahmatullah, M. (2026) · Heliyon · doi:10.1016/j.heliyon.2026.e44524 · Cited by 6
Self-citationMahapatra, A. D., Paul, I., Dasgupta, S., Roy, O., Sarkar, S., Ghosh, T., Basu, S., & Chattopadhyay, D. (2024) · Chemistry & Biodiversity · doi:10.1002/cbdv.202401913 · Cited by 7
Erratum: A Review of Marine Natural Product Resources with Potential Bioactivity Against SARS-COV-2
Mishra, N., Gupta, E., Walag, A. M. P., Kharwar, R. N., Singh, P., & Mishra, P. (2023) · Tropical Journal of Natural Product Research · doi:10.26538/tjnpr/v7i1.2 · Cited by 6
Current and Prospective Pharmaceutical Use of Algal Bioproducts
Leung, E. H. W. (2025) · IntechOpen eBooks · doi:10.5772/intechopen.1009486 · Cited by 5
Rodríguez-Valdez, G., Romero-Geraldo, R. D. J., Basulto, G. E. M., Reyes‐Becerril, M., & Angulo, C. (2022) · Indian Journal of Microbiology · doi:10.1007/s12088-022-01002-3 · Cited by 4
“In general, physicochemical conditions of extreme niches promote the development of several tolerant microorganisms and a myriad of biomolecules that can act as immunomodulators [13].”
BackgroundEngineering recombinantly expressed lectin-based antiviral agents
Maier, I. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.990875 · Cited by 8
Raghunathan, S., Navabshan, I., Badar, B., Kim, J., & MubarakAli, D. (2022) · Biocatalysis and Agricultural Biotechnology · doi:10.1016/j.bcab.2022.102585 · Cited by 4
Spirulina (Arthrospira spp) as a Complementary COVID-19 Response Option: Early Evidence of Promise
Siedenburg, J., & Cauchi, J. P. (2022) · Current Research in Nutrition and Food Science Journal · doi:10.12944/crnfsj.10.1.10 · Cited by 5
Cyanobacteria and microalgae as promising sources of novel bioactive compounds: A review
Singh, S., Dwivedi, S., Shukla, M. K., Verma, A. K., Siddique, G. A., & Singh, D. K. (2025) · Journal of Advances in Microbiology Research · doi:10.22271/micro.2025.v6.i2c.263 · Cited by 3
Iqbal, M. N., Vinoth, S., Sasikanth, V., & Rathinavel, T. (2023) · Polycyclic aromatic compounds · doi:10.1080/10406638.2023.2210728 · Cited by 3
Algal proteins, peptides and amino acids
Flórez-Fernández, N., Ravindran, R., Balboa, E. M., Torres, M. D., & Falqué, E. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-98819-3.00001-8 · Cited by 2
Besednova, N. N., Zaporozhets, T. S., Andryukov, B. G., Ermakova, S. P., Kuznetsova, T. A., Kryzhanovsky, S. P., & MIu, S. (2022) · Antibiot Khimioter = Antibiotics and Chemotherapy · doi:10.37489/0235-2990-2022-67-3-4-53-69 · Cited by 2
Do Marine Polysaccharides Carrageenans Modulate Non-apoptotic Regulated Cell Deaths ? (a Review)
Tkachenko, A. S., Onishchenko, A. I., & Prokopіuk, V. (2023) · Current Pharmacology Reports · doi:10.1007/s40495-023-00339-7 · Cited by 2
“A growing body of evidence indicates that CGNs hold potential of becoming effective anti-viral [3, 59–62], anti-cancer [63–65], prebiotic [66], anti-photoaging [67], metal-binding [68], immunomodulatory [63, 69], antioxidant [70], anti-coagulant [71], microbicidal [72], endotoxin-neutralizing [73],…”
BackgroundIn vitro antiviral activity of Chlorella vulgaris extracts and fractions against SARS-CoV-2
Astorga-González, B., Villalobos-Sánchez, E., Gutiérrez‐Ortega, A., Madrigal, J. B., Mateos‐Díaz, J. C., & Elizondo‐Quiroga, D. (2025) · Natural Product Research · doi:10.1080/14786419.2025.2499920 · Cited by 1
“Sulphated polysaccharides, rich in glucose, galactose, and mannose, have been shown to play a critical role in blocking viral entry and exhibiting antiviral activity against hSV, hIV-1, influenza, and SARS-CoV-2 (Alam et al. 2021; Mirzaie et al. 2021; Salih et al. 2021).”
Chebotarev, S. A., Antipova, A. S., Martirosova, E. I., Palmina, N. P., Zelikina, D. V., Anokhina, M. S., Bogdanova, N. G., Kasparov, V. V., Balakina, E., Komarova, A., et al. (2022) · International Dairy Journal · doi:10.1016/j.idairyj.2022.105402 · Cited by 1
Nanotechnology: New frontiers in anti-HIV therapy
Jampílek, J., & Kráľová, K. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-99596-2.00011-x · Cited by 1
Antiviral Phytocompounds Against Animal-to-Human Transmittable SARS-CoV-2
Biswas, P., Parvez, A., Abdullah, A., Rahaman, T. I., Dey, D., Ahmmed, S., Mia, M. A. R., Das, R. C., Sultana, S., & Bibi, S. (2023) · Springer eBooks · doi:10.1007/978-981-99-3664-9_7 · Cited by 2
Food waste leachate valorization for sustainable biomass production from Arthrospira maxima
Hernández-Gaytán, K. S., García‐Gómez, C., Suárez-Vázquez, S. I., Carballo-Méndez, F. D. J., Márquez‐Reyes, J. M., & Chávez-Santoscoy, R. A. (2023) · Environmental Progress & Sustainable Energy · doi:10.1002/ep.14327 · Cited by 1
Yuan, Y., & Oomah, B. D. (2022) · Wiley eBooks · doi:10.1002/9781119804055.ch8
al., A. S. H. E. (2023) · Egyptian Journal of Aquatic Biology and Fisheries · doi:10.21608/ejabf.2023.317396
“Bioactive molecules and/or compounds derived from algae offer potential health benefits and diverse applications, such as anti-cancer, anti-diabetic, antiinflammatory, antioxidant, anti-obesity, and neuroprotective (Alam et al., 2021).”
BackgroundRetrosynthetic Analysis of the Synthetic Pathway for Antineocyclocitrinol A
Chen, S. (2023) · Studies in health technology and informatics · doi:10.3233/shti230908
New Perspectives and Sustainability Against Climate Change: Microalgae As Feed Sources
Sucu, M. C., & Şanlı, N. Ö. (2024) · doi:10.69860/nobel.9786053359258.4
Evaluating microbial products as potential SARS-CoV-2 inhibitors
Mawooa, S. J., Bikoo, H., Chumrah, Y., Boodhun, K. D., Daworaz, K., Alrefaei, A. F., & Jeewon, R. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-18757-5.00013-x
Eswaramoorthi, M. P., Subramanian, G., Rajeswari, S., Debora, J. J., Varadarajan, V., KARUNAKARAN, G. A., & Rethinam, B. (2025) · Biologia · doi:10.1007/s11756-025-01927-2
“Hence, considering COVID-19 vaccines incorporating these compounds for future development is warranted (Song et al. 2020; Alam et al. 2021; Hans et al. 2021; Ratha et al. 2021; Ziyaei et al. 2022).”
Harnessing nature's potential: Exploring the possibilities for disease therapeutics from algae
Choudhari, J. K., Anandkumar, J., Choubey, J., Tripathi, A., Pandey, S., & Sahariah, B. P. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-23796-6.00012-2
สาหร่าย: แหล่งอาหารทางเลือกเพื่อการบริโภค
ธุระกิจ, ธ. (2025) · วารสารวิจัยและพัฒนาผลิตภัณฑ์อาหาร · doi:10.56825/jfrpd.2025.5516211
Udeh, B. O., & Nweze, N. O. (2025) · Bio Research Journal/Bio- Research · doi:10.4314/br.v23i2.2
Marine algal bioactive potential in medicinal field
Li, Q., & Jin, Z. (2026) · Studies in natural products chemistry · doi:10.1016/b978-0-443-51070-0.00007-0
Metadata
- Authors
- Alam, M. A., Parra-Saldivar, R., Bilal, M., Afroze, C. A., Ahmed, M. N., Iqbal, H. M. N., & Xu, J.
- Affiliations
- Zhengzhou University (CN)
- Tecnologico de Monterrey, School of Engineering and Sciences, Monterrey 64849, Mexico
- Huai'an University (CN)
- University of Development Alternative (BD)
- Biotechnology & Natural Medicine Division, TechB Nutrigenomics, Dhaka 1209, Bangladesh
- Tecnológico de Monterrey (MX)
- Corresponding author
- Iqbal, Hafiz M.N.
- Xu, Jingliang
- ORCID
- Venue
- Molecules
- Publisher
- MDPI AG
- Published
- 2021-04-08
- Volume
- 26
- Issue
- 8
- Pages
- 2134
- ISSN
- 1420-3049 (ISSN-L)
- PMC
- PMC8068085
- OpenAlex
- W3147076663
- Cited by
- 69
- References
- 116
- Citations by year
- 2026: 3 · 2025: 9 · 2024: 7 · 2023: 13 · 2022: 31 · 2021: 6
- FWCI
- 1.30
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Molecules (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Consejo Nacional de Ciencia y Tecnología (735340, CVU: 735340)
- Sistema Nacional de Investigadores (CVU: 735340, 735340)
- Topics
- Life Sciences › Agricultural and Biological Sciences › Aquatic Science › Seaweed-derived Bioactive Compounds
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Life Sciences › Agricultural and Biological Sciences › Plant Science › Medicinal Plant Research
- Keywords
- SARS-CoV-2, COVID-19 pandemic, antiviral activity, marine bioproducts
- MeSH terms
- COVID-19, SARS-CoV-2, COVID-19 Drug Treatment, Phaeophyceae, Chlorophyta, Rhodophyta, Antiviral Agents, Carrageenan, Humans, Polysaccharides, Lectins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.